No Detail Found!

Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine on Haemodynamic Parameters in Patients Undergoing Transurethral Resection of Prostate

Author(s)
Nida Shafqat Department of Anaesthesiology, SICU, and Pain Management, Sindh Institute of Urology and Transplantation (SIUT),Karachi,Pakistan
Syed Muhammad Abbas Department of Anaesthesiology, SICU, and Pain Management, Sindh Institute of Urology and Transplantation (SIUT),Karachi,Pakistan
Muhammad Qamar Abbas Department of Anaesthesiology, SICU, and Pain Management, Sindh Institute of Urology and Transplantation (SIUT),Karachi,Pakistan
Muhammad Faisal Farooq Department of Anaesthesiology, SICU, and Pain Management, Sindh Institute of Urology and Transplantation (SIUT),Karachi,Pakistan
Muhammad Siddique Department of Anaesthesiology, SICU, and Pain Management, Sindh Institute of Urology and Transplantation (SIUT),Karachi,Pakistan
Shakeel Malik Department of Anaesthesiology, SICU, and Pain Management, Sindh Institute of Urology and Transplantation (SIUT),Karachi,Pakistan
Abstract
Objective: To determine the role of dexmedetomidine in potentiating the local anaesthetic e cacy of a low dose of bupivacaine when used as an adjuvant. Study Design: A prospective, double-blind, randomised study. Place and Duration of the Study: Department of Anaesthesia, Sindh Institute of Urology and Transplantation, Karachi, Pakistan, from July 2021 to February 2022. Methodology: One hundred and eight patients of ASA physical class I-III undergoing transurethral resection of the prostate (TURP) under sub-arachnoid block (SAB) were enroled and distributed into two equal groups. Group BUPIPURE (BP) was given 7.5 mg of pure 0.5% hyperbaric bupivacain whereas group BUPIDEX (BD) was given 6 mg of 0.5% hyperbaric bupivacain with 3¼gdexmedetomidine intrathecally. The e ects in Both groups were compared using chi-square and unpaired t-tests. A signi cance level of p <0.05 was used to evaluate the statistical signi cance. Results: Both groups demonstrated a steady decrease in mean heart rate (mean HR98.9-62.7 per minute as compared to 79.1-59.4 per minute in groups BP and BD, respectively), however, no patient reached to HR <50/min. Group BP had a higher HR variability than group BD. The two groups' median peak sensory levels were similar. However, a statistically signi cant di erence was revealed in the time taken for 2-segment regression (87.5 ± 11.3 min vs. 115.5 ± 6.2 min p <0.001 in BP and BD), as well as the time to reach T10 sensory level (13.56 ± 2.5 min vs. 10.9 ± 3.0 min p <0.001). Conclusion: In patients having TURP, intrathecal dexmedetomidine combined with low-dose bupivacaine results in a quicker start, extended sensory and motor block, and a decreased need for rescue analgesics.
Publication Details
Page(s) 1014-1018
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 9, Year: 2024

Request the full text from PASTIC

Keywords
Spinal anaesthesia, Dexmedetomidine, Transurethral resection of prostate, Adjuvants
0

Citations

0

Downloads

78

Views